Prevalence of atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis

Pakistan Journal of Medical Sciences

Volumn 31, Issue 5, 2015, Pages 1078-1083

  Kisiel, Bartłomiej ^a,b   Kruszewski, Robert ^a   Juszkiewicz, Aleksandra ^a   Kłos, Krzysztof ^b   Tłustochowicz, Małgorzata ^a   Tłustochowicz, Witold ^a,b  

^a Department of Internal Diseases and Rheumatology ^*  (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Atherosclerosis; Diabetes mellitus; Rheumatoid arthritis

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RHEUMATOID ARTHRITIS; SUPERFICIAL FEMORAL ARTERY;

EID: 84945294716     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.315.7620     Document Type: Article

References (20)

1. del Rinc�n I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737-2745.
2. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, et al. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes. Arterioscler Thromb Vasc Biol. 2009;29(10):1702-1708. doi: 10.1161/ATVBAHA.109.190108
3. van Halm VP, Peters MJL, Voskuyl AE, Boers M, Lems WF, Wisser M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis. 2009;68(9):1395-1400. doi: 10.1136/ard.2008.094151
4. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. J Rheumatol. 2006;33(11):2167-2172.
5. Simard JF, Mittleman MA. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol. 2007;34(3):469-473.
6. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum. 2004;50(11):3444-3449.
7. Wasko MC, Kay J, Hsia EC, Rahman MU. Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in chronic inflammatory disease. Arthritis Care Res. 2011;63(4):512-521.
8. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196(2):756-763.
9. Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264-270. doi: 10.1016/j.jacc.2007.09.038
10. Dessein PH, Tobias M, Veller MG. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2006;33(12):2425-2432.
11. Li L, Yu H, Zhu J, Wu X, Liu F, Zhang F, et al. The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients. J Diabetes Compl. 2012;26(1):23-28.doi: 10.1016/j.jdiacomp.2011.11.006
12. Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tłustochowicz M, et al. Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis. J Immunol Res, Article ID 759610, in press.
13. W�lberg-Jonsson S, Johansson H, Ohman ML, Rantap��- Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: a retrospective cohort study from disease onset. J Rheumatol. 1999;26(12):2562-2571.
14. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52(3):722-732.
15. del Rincon I, Freeman GL, Haas RW, O’Leary DH, Escalante A. Relative contribution of CV risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52(11):3413-3423.
16. del Rincon I, Williams K, Stern MP, Freeman GL, O’Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 2003;48(7):1833-40.
17. Pamuk ON, Unlu E, Cakir N. Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol. 2006;33(12):2447-2452.
18. La Montagna G, Cacciapuoti F, Buono R, Manzella D, Mennillo GA, Arciello A, et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis. 2007;4(2):130-135.
19. Protogerou A, Zampeli E, Tentolouris N, Makrilakis K, Kitas G, Sfikakis PP.Sublinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a casecontrol study. Ann Rheum Dis. 2012;71(9):1534-1536. doi: 10.1136/annrheumdis-2011-201278
20. Danese C, Vestri AR, D’Alfonso V, Deriu G, Dispensa S, Baldini R, et al. Do hypertension and diabetes mellitus influence the site of atherosclerotic plaques? Clin Ter. 2006;157(1):9-13.